Charles Schwab Investment Management Inc Frequency Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.46 - $2.55 $34,111 - $59,578	23,364 New	23,364 $42,000
Q2 2022 Aug 15, 2022	SELL	$1.03 - $2.03 $78,021 - $153,770	-75,749 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.7 - $5.72 $5,487 - $18,464	-3,228 Reduced 4.09%	75,749 $161,000
Q3 2021 Nov 16, 2021	SELL	$6.96 - $9.25 $854,875 - $1.14 Million	-122,827 Reduced 60.86%	78,977 $558,000
Q2 2021 Aug 16, 2021	BUY	$8.05 - $11.61 $24,689 - $35,607	3,067 Added 1.54%	201,804 $2.01 Million
Q1 2021 May 17, 2021	BUY	$7.99 - $55.01 $47,692 - $328,354	5,969 Added 3.1%	198,737 $1.89 Million
Q4 2020 Feb 16, 2021	BUY	$18.65 - $40.0 $24,599 - $52,760	1,319 Added 0.69%	192,768 $6.8 Million
Q3 2020 Nov 13, 2020	BUY	$17.76 - $24.96 $1.79 Million - $2.51 Million	100,525 Added 110.56%	191,449 $3.68 Million
Q2 2020 Aug 14, 2020	BUY	$14.65 - $24.9 $807,112 - $1.37 Million	55,093 Added 153.76%	90,924 $2.11 Million
Q1 2020 May 15, 2020	BUY	$16.36 - $27.55 $8,409 - $14,160	514 Added 1.46%	35,831 $639,000
Q4 2019 Feb 07, 2020	BUY	$12.67 - $18.73 $447,466 - $661,487	35,317 New	35,317 $620,000

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.